Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Global warming may raise women’s cancer risk
Scientists investigating the impact of climate change on women’s health have found that increased heat…
In vitro cancer model reveals how tumour cells access the bloodstream
Tumours are made up of millions of cells, and removing all of these cells surgically…
Scientific breakthrough: We can now halve the price of costly cancer drug
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical and…
Cancer groundshot: Access to proven treatments must parallel development of new therapies
Bishal Gyawali, Queen’s University, Ontario Where should investment be made today in order to save the maximum number of lives…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.